An Observational Study, Called RegoFlex EU, to Learn More About the Use of Stivarga at Reduced Doses as Recommended (Flexible Dosing) to Treat People With Metastatic Colorectal Cancer in Real World Settings in Europe
Clinical trial NCT05551039 · COMPLETED
Trial details
- NCT number
- NCT05551039
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-15
- Primary completion
- 2023-01-15
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.